The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISAL 2019 | Twitter: expediting critical research analysis
“Social media plays an ever increasing role in all aspects of modern day life, with healthcare and medical communication being no exception. We spoke to Twitter-user Klaus Metzeler, MD, of LMU Hospital Munich, Munich, Germany, about the role of social media for healthcare professionals and researchers. This interview took place at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.
